KT&G expands sales of Lil AIBLE e-cigarettes.

Dec.13.2022
KT&G expands sales of Lil AIBLE e-cigarettes.
KT&G expands Lil AIBLE e-cigarette sales to 20,000 stores in South Korea, including major cities like Busan and Seoul.

On the 12th, KT&G announced that it will expand the sales network for its newly launched e-cigarette, "lil AIBLE," to 20,000 locations.


Starting from the 13th, a total of 11,095 convenience stores will be added to major cities including Busan, Incheon, Daegu, and Gwangju in the four metropolitan areas as well as major cities such as Sejong, Suwon, and Seongnam.


On the 16th of last month, "Lil Able" started selling in 8,500 convenience stores in Seoul, including flagship store "lil MINIMALIUM" and online retailer "Lil Store", and then expanded its sales to 233 major convenience stores nationwide on the 30th.


Taking convenience stores as an example, out of the four Lil Able products available, two are sold in blue and white. All Lil Able devices, including premium products, can be purchased at both Lil Minimalium and Lil Store.


On the official website of Lil (https://its-lil.com), customers who have completed adult authentication and membership registration can purchase products at discounted prices using coupons priced at 167,000 Korean won (approximately 895 yuan) and 99,000 Korean won (approximately 531 yuan) respectively.


A spokesperson for KT&G stated, "Lil Able can utilize three types of proprietary pods on one device, which is quite convenient for consumers.


2FIRSTS will continue to cover this topic and provide updates on the "2FIRSTSAPP". Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
Philip Morris International (PMI) released its Q4 and full-year 2025 results on February 6, 2026. PMI reported full-year net revenues of $40,648 million ($40.6 billion), reported diluted EPS of $7.26 and adjusted diluted EPS of $7.54. PMI said smoke-free net revenues were $16.9 billion and represented 41.5% of total net revenues, with smoke-free products available in 106 markets and over 43 million estimated adult consumers.
Feb.06 by 2FIRSTS.ai
PMI Sells Stake in Swedish Match Brazil Business, Including Fiat Lux Brand
PMI Sells Stake in Swedish Match Brazil Business, Including Fiat Lux Brand
Philip Morris International said it is selling its stake in Swedish Match do Brasil, which controls the Brazilian household goods brand Fiat Lux. The buyer is Ignis FIP, a Brazilian private investment vehicle backed by businessman Marcos Fernando Garms. The transaction also includes Swedish Match da Amazônia, but the value of the deal was not disclosed. PMI said the sale is aligned with its vision of a smoke-free future.
Mar.20 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
Study Says Europe’s Illicit Disposable Vape Market to Reach EUR 6.6 Billion in 2026
A new study by the Fraunhofer Institute says the rapidly expanding illicit market for disposable e-cigarettes is undermining European regulation, fuelling youth vaping and causing significant tax losses. The study says the illicit market is worth EUR 6.6 billion in 2026 and is projected to rise to EUR 10.8 billion by 2030. It adds that a significant share of the disposable vape market now operates outside the regulatory framework established by the EU Tobacco Products Directive.
Mar.13 by 2FIRSTS.ai